Ovarian cancer is the fifth leading cause of cancer-induced death in women. There are 180,000 women affected worldwide, and 22,000 in the U.S. When it is detected, many times it’s too late, and prognosis is poor. The 5-year survival rate for patients diagnosed at stages III or IV is only 20% to 25% compared to approximately 95% for stages I or II.
The challenge has to do with current testing, which fails to effectively detect ovarian cancer early enough. If we can find ovarian cancer earlier, before it has spread beyond the ovary, there is hope that survival rates will improve.